2.64
-0.063(-2.33%)
Currency In USD
| Previous Close | 2.7 |
| Open | 2.68 |
| Day High | 2.74 |
| Day Low | 2.6 |
| 52-Week High | 4.18 |
| 52-Week Low | 2.25 |
| Volume | 23,686 |
| Average Volume | 64,074 |
| Market Cap | 9.06M |
| PE | -0.79 |
| EPS | -3.35 |
| Moving Average 50 Days | 2.78 |
| Moving Average 200 Days | 3.15 |
| Change | -0.06 |
If you invested $1000 in Kiora Pharmaceuticals, Inc. (KPRX) 10 years ago, it would be worth $0.12 as of September 12, 2025 at a share price of $2.65. Whereas If you bought $1000 worth of Kiora Pharmaceuticals, Inc. (KPRX) shares 5 years ago, it would be worth $1.92 as of September 12, 2025 at a share price of $2.65.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Kiora Pharmaceuticals to Webcast On-Demand Presentation at The H.C. Wainwright 27th Annual Global Investment Conference
Newsfile
Sep 04, 2025 11:00 AM GMT
Encinitas, California--(Newsfile Corp. - September 4, 2025) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) today announced that its Chief Financial Officer, Melissa Tosca, CPA, will showcase the Company's pipeline of therapies targeting inherited and i
Kiora Pharmaceuticals to Showcase Its Retinal Disease Therapeutic Pipeline at The H.C. Wainwright 5th Annual Ophthalmology Virtual Conference
Newsfile
Aug 07, 2025 11:00 AM GMT
Encinitas, California--(Newsfile Corp. - August 7, 2025) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) today announced that its President and CEO, Brian M. Strem, Ph.D., will showcase the Company's pipeline of therapies targeting inherited and inflamm
Kiora Pharmaceuticals Granted U.S. Patent Expanding Protection for KIO-104 in the Treatment of Ocular Disease
Newsfile
Jul 22, 2025 12:55 PM GMT
Encinitas, California--(Newsfile Corp. - July 22, 2025) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) today announced it has received a patent (US Patent No. 12,364,680) covering KIO-104 for the treatment of a wide range of ocular diseases. This inclu